Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the second quarter 2024 before market open on Tuesday, July 30, 2024.
2024年7月9日，西雅图（全球新闻社）- 鹦鹉螺体育公司（纳斯达克股票代码：NAUT或“鹦鹉螺体育”），是一家开创性的单分子蛋白质分析平台公司，宣布将于2024年7月30日星期二市场开盘前公布2024年第二季度财务业绩。
The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: .
公司管理层将从太平洋时间早上5:30 / 东部时间早上8:30开始网络直播相应的电话会议，以讨论其业绩、业务发展和前景。网络直播的实况音频将在公司网站的"投资者"板块上提供：。
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit .
关于Nautilus Biotechnology，Inc。
鹦鹉螺体育公司总部位于华盛顿州西雅图市，研发总部位于加利福尼亚州圣卡洛斯市，是一家发展阶段的生命科学公司，致力于创建一个量化和揭示蛋白质组复杂性的平台技术。鹦鹉螺体育的使命是通过民主化进入蛋白质组并在人类健康和医学领域实现根本性的进步，来改变蛋白质组学领域。欲了解更多关于鹦鹉螺体育，请访问.
Media Contact
press@nautilus.bio
媒体联系人
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
投资者联系方式
investorrelations@nautilus.bio